Use of fluoxetine to reduce weight in adults with overweight or obesity: Abridged republication of the Cochrane Systematic Review
Introduction: Using fluoxetine is one of many weight-loss strategies. A serotonin reuptake inhibitor indicated for depression believed to impact weight control by changing an individual’s appetite; however, its benefit-risk ratio is unclear. The aim of this review is to assess the efficacy and safet...
Main Authors: | Aurora E. Serralde-Zuñiga, Alejandro G. González-Garay, Yanelli Rodríguez-Carmona, Guillermo Meléndez-Mier |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2022-06-01
|
Series: | Obesity Facts |
Online Access: | https://www.karger.com/Article/FullText/524995 |
Similar Items
-
Colesevelam for Type 2 diabetes mellitus: an abridged Cochrane review
by: Ooi, Cheow Peng, et al.
Published: (2014) -
Nonpharmacological Management of Procedural Pain in Infants and Young Children: An Abridged Cochrane Review
by: Rebecca Pillai Riddell, et al.
Published: (2011-01-01) -
Intravesical gemcitabine for non-muscle invasive bladder cancer: An abridged Cochrane Review
by: Mi Ah Han, et al.
Published: (2021-11-01) -
Exercise for preventing falls in older people living in the community: an abridged Cochrane Systematic Review
by: Sherrington, C, et al.
Published: (2019) -
Cochrane method for systematic review and meta-analysis of interventions to prevent occupational noise-induced hearing loss – abridged
by: Christina Tikka, et al.
Published: (2020-04-01)